158 related articles for article (PubMed ID: 24392140)
1. Elevated peptides in lung lavage fluid associated with bronchiolitis obliterans syndrome.
Stone MD; Harvey SB; Nelsestuen GL; Reilly C; Hertz MI; Wendt CH
PLoS One; 2014; 9(1):e84471. PubMed ID: 24392140
[TBL] [Abstract][Full Text] [Related]
2. Proteomic bronchiolitis obliterans syndrome risk monitoring in lung transplant recipients.
Wolf T; Oumeraci T; Gottlieb J; Pich A; Brors B; Eils R; Haverich A; Schlegelberger B; Welte T; Zapatka M; von Neuhoff N
Transplantation; 2011 Aug; 92(4):477-85. PubMed ID: 21716170
[TBL] [Abstract][Full Text] [Related]
3. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation.
Zheng L; Walters EH; Ward C; Wang N; Orsida B; Whitford H; Williams TJ; Kotsimbos T; Snell GI
Thorax; 2000 Jan; 55(1):53-9. PubMed ID: 10607802
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome.
Badri L; Murray S; Liu LX; Walker NM; Flint A; Wadhwa A; Chan KM; Toews GB; Pinsky DJ; Martinez FJ; Lama VN
Am J Respir Crit Care Med; 2011 Apr; 183(8):1062-70. PubMed ID: 21169468
[TBL] [Abstract][Full Text] [Related]
7.
Ciaramelli C; Fumagalli M; Viglio S; Bardoni AM; Piloni D; Meloni F; Iadarola P; Airoldi C
J Proteome Res; 2017 Apr; 16(4):1669-1682. PubMed ID: 28245130
[TBL] [Abstract][Full Text] [Related]
8. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
Jaksch P; Taghavi S; Klepetko W; Salama M
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
[TBL] [Abstract][Full Text] [Related]
10. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.
Hardison MT; Galin FS; Calderon CE; Djekic UV; Parker SB; Wille KM; Jackson PL; Oster RA; Young KR; Blalock JE; Gaggar A
J Immunol; 2009 Apr; 182(7):4423-31. PubMed ID: 19299743
[TBL] [Abstract][Full Text] [Related]
11. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
[TBL] [Abstract][Full Text] [Related]
12. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?
Vos R; Vanaudenaerde BM; Geudens N; Dupont LJ; Van Raemdonck DE; Verleden GM
Eur Respir J; 2008 May; 31(5):1037-45. PubMed ID: 18256072
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome.
Anderson RL; Hiemstra PS; Ward C; Forrest IA; Murphy D; Proud D; Lordan J; Corris PA; Fisher AJ
Eur Respir J; 2008 Sep; 32(3):670-7. PubMed ID: 18508823
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation.
Hübner RH; Meffert S; Mundt U; Böttcher H; Freitag S; El Mokhtari NE; Pufe T; Hirt S; Fölsch UR; Bewig B
Eur Respir J; 2005 Mar; 25(3):494-501. PubMed ID: 15738294
[TBL] [Abstract][Full Text] [Related]
16. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
[TBL] [Abstract][Full Text] [Related]
18. Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation.
Kelly FL; Kennedy VE; Jain R; Sindhwani NS; Finlen Copeland CA; Snyder LD; Eu JP; Meltzer EB; Brockway BL; Pavlisko E; Stripp BR; Palmer SM
Am J Transplant; 2012 Nov; 12(11):3076-84. PubMed ID: 22883104
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa Induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction.
Borthwick LA; Suwara MI; Carnell SC; Green NJ; Mahida R; Dixon D; Gillespie CS; Cartwright TN; Horabin J; Walker A; Olin E; Rangar M; Gardner A; Mann J; Corris PA; Mann DA; Fisher AJ
Am J Transplant; 2016 Jun; 16(6):1751-65. PubMed ID: 26714197
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
